How do you interpret diagnostics and genomics — goodwill impairment loss net of tax?

An increase signals poor performance of past acquisitions or a deterioration in the segment's market outlook.

Bio-Techne TECH Diagnostics And Genomics — Goodwill Impairment Loss Net Of Tax

Discontinued — last reported Q2 '22

Similar metrics at other companies

ADiagnostics and Genomics — Goodwill, Written off Related to Sale of Business Unit

$3.25M—

LHLab Corp Diagnostics — Goodwill Impairment

$3.7M0.0%

GTLSBiomedical — Goodwill Impairment

$32.81M—

LHLab Corp Diagnostics — Goodwill And Intangible Asset Impairment

$11M—

LHLabCorp Diagnostics — Goodwill and Intangible Asset Impairment

$2.9M—

BIO.BClinical Diagnostics — Goodwill, Impairment Loss

——

Other financials

Income statement

See full

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

See full

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

See full

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

See full

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

See full

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

See full

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLossNetOfTax.

The official record: Bio-Techne’s 10-Q, filed February 7, 2022, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's diagnostics and genomics — goodwill impairment loss net of tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Techne's diagnostics and genomics — goodwill impairment loss net of tax?: Bio-Techne (TECH) reported diagnostics and genomics — goodwill impairment loss net of tax of -$0 in Q4 2021.
What does diagnostics and genomics — goodwill impairment loss net of tax mean?: The loss recorded when the value of acquired goodwill in the diagnostics and genomics segment drops below its book value.
How do you interpret diagnostics and genomics — goodwill impairment loss net of tax?: An increase signals poor performance of past acquisitions or a deterioration in the segment's market outlook.
How does diagnostics and genomics — goodwill impairment loss net of tax compare across companies?: A negative indicator of capital allocation efficiency and business unit health.